Reframing Treatment-Resistant Depression as Difficult-to-Treat Depression
The article recommends shifting from the label treatment-resistant depression to difficult-to-treat depression. It advises clinicians to confirm that patients received adequate trials and to identify factors such as trauma and inflammation that may shape outcomes.
The article recommends moving from the term “treatment-resistant depression” to “difficult-to-treat depression.” This reframing concerns how clinicians describe and approach depression that has not improved with treatment. The article also advises confirming that patients received adequate trials and identifying factors such as trauma and inflammation that may shape outcomes. These elements place the discussion within broader conversations about how mental health conditions are named and evaluated.
The proposed terminology shift could affect patients, clinicians, and families by changing how difficult-to-treat depression is discussed and assessed. Confirming adequate treatment trials and considering trauma and inflammation may lead to more tailored evaluations. This could improve communication and reduce blame, though its real-world impact may depend on how widely clinicians adopt the reframing and whether they can act on the factors identified.